Cross‐reactivity of human lupus anti‐DNA antibodies with α‐actinin and nephritogenic potential
The DOI matches its Crossref record.
Abstract
Objective: Cross‐reactivity with kidney antigens is believed to be a critical determinant in the renal pathogenicity of anti–double‐stranded DNA (anti‐dsDNA) antibodies. Murine nephritogenic anti‐dsDNA antibodies have been shown to cross‐react with α‐actinin, and anti–α‐actinin antibodies have been found to be deposited in the kidneys of lupus mice with active nephritis. Furthermore, in humans with systemic lupus erythematosus (SLE), it has been found that a greater proportion of polyclonal IgG anti‐dsDNA antibodies from patients with renal involvement bind to α‐actinin than do those from patients without renal disease. We undertook this study to substantiate a direct link between cross‐reactive anti‐dsDNA/anti–α‐actinin antibodies and the pathogenesis of lupus nephritis in humans. Methods: A panel of 10 anti‐dsDNA and/or anti–α‐actinin antibodies was generated by Epstein‐Barr virus transformation of lymphocytes from patients with SLE and was extensively characterized. Antibody binding was studied by enzyme‐linked immunosorbent assay and Western blotting. Antibody potential for pathogenicity was assessed by measuring binding to isolated glomeruli and mesangial cells and by evaluation of histologic features of the kidney following injection in vivo. Results: All anti‐dsDNA antibodies isolated also bound α‐actinin. Cross‐reactive antibodies bound to mesangial cells and to isolated glomeruli ex vivo. Binding to glomeruli was not inhibited by DNase treatment, but could be abrogated by α‐actinin. Furthermore, histopathologic abnormalities seen in mice injected intraperitoneally with a cross‐reactive cell line included fusion of podocyte foot processes and subepithelial and subendothelial deposition. Conclusion: These studies provide strong support for the hypothesis that α‐actinin is a major cross‐reactive target for anti‐dsDNA antibodies in SLE patients. Cross‐reactive anti‐dsDNA/anti–α‐actinin antibodies from SLE patients are pathogenic and may contribute to the kidney lesions in lupus nephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neuropsychiatric lupus: new mechanistic insights and future treatment directions
Schwartz, N., Stock, A. D., & Putterman, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0156-8 · Cited by 429
Self-citationFifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Anti-DNA antibodies–quintessential biomarkers of SLE
Pisetsky, D. S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.151 · Cited by 267
Manson, J. J., Ma, A., Rogers, P., Mason, L. J., Berden, J. H., van der Vlag, J., D'Cruz, D. P., Isenberg, D. A., & Rahman, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2831 · Cited by 129
Rekvig, O. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01104 · Cited by 65
Metadata
- Authors
- Zhao, Z., Weinstein, E., Tuzova, M., Davidson, A., Mundel, P., Marambio, P., & Putterman, C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-02
- Volume
- 52
- Issue
- 2
- Pages
- 522-530
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2029499211
- Cited by
- 116
- References
- 0
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cross‐reactivity of human lupus anti‐DNA antibodies with α‐actinin and nephritogenic potential. https://app.cochat.ai/papers/10.1002/art.20862
- The paper
- Zhao, Z., Weinstein, E., Tuzova, M., Davidson, A., Mundel, P., Marambio, P., & Putterman, C. (2005). Cross‐reactivity of human lupus anti‐DNA antibodies with α‐actinin and nephritogenic potential. Arthritis & Rheumatism. https://doi.org/10.1002/art.20862
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.